FDA
approval
· 2018-08-22
FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Amneal Pharmaceuticals NY LLC)
Summary
FDA approved Amneal Pharmaceuticals' generic fixed-dose combination emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) for treatment of HIV-1 infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)